Retirement Systems of Alabama Has $17.57 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Retirement Systems of Alabama lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 214,603 shares of the company’s stock after selling 1,694 shares during the quarter. Retirement Systems of Alabama’s holdings in HealthEquity were worth $17,565,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Raymond James Trust N.A. boosted its stake in HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares in the last quarter. Truist Financial Corp boosted its stake in shares of HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after purchasing an additional 188 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of HealthEquity by 7.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after purchasing an additional 198 shares during the last quarter. Elk River Wealth Management LLC increased its position in HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC increased its position in HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now directly owns 66,469 shares in the company, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,786 shares of company stock worth $4,140,387 over the last quarter. Company insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 0.7 %

Shares of NASDAQ HQY opened at $95.62 on Friday. The company’s 50 day moving average price is $94.06 and its 200-day moving average price is $84.22. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The company has a market capitalization of $8.29 billion, a P/E ratio of 87.72, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55.

Analysts Set New Price Targets

A number of analysts have weighed in on HQY shares. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Barrington Research increased their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.